Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk

Nutritional markers, such as lean body mass (LBM) and serum albumin, predict outcome in dialysis patients, in whom protein-energy malnutrition is associated with increased morbidity and mortality. The metabolic effects of human growth hormone (hGH) may improve the nutritional and cardiovascular heal...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the American Society of Nephrology 2007-07, Vol.18 (7), p.2161-2171
Hauptverfasser:	FELDT-RASMUSSEN, Bo, LANGE, Martin, SULOWICZ, Wladyslaw, GAFTER, Uzi, KAR NENG LAI, WIEDEMANN, Jonas, CHRISTIANIEN, Jens Sandal, EL NAHAS, Meguid
Format:	Artikel
Sprache:	eng
Schlagworte:	Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Cardiovascular Diseases - prevention & control Double-Blind Method Emergency and intensive care: renal failure. Dialysis management Human Growth Hormone - therapeutic use Humans Intensive care medicine Medical sciences Middle Aged Nephrology. Urinary tract diseases Nutritional Status Quality of Life Renal Dialysis Risk Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!